Posttranslational modifications of NLRP3 and their regulatory roles in inflammasome activation
Authors:
- 29 June 2023
- journal article
- review article
- Published by Wiley in European Journal of Immunology
- Vol. 53 (10) , e2350382
Abstract
The NACHT, LRR, and PYD domains‐containing protein 3 (NLRP3) inflammasome is a multimolecular complex that plays a fundamental role in inflammation. Optimal activation of NLRP3 inflammasome is crucial for host defense against pathogens and the maintenance of immune homeostasis. Aberrant NLRP3 inflammasome activity has been implicated in various inflammatory diseases. Posttranslational modifications (PTMs) of NLRP3, a key inflammasome sensor, play critical roles in directing inflammasome activation and controlling the severity of inflammation and inflammatory diseases, such as arthritis, peritonitis, inflammatory bowel disease, atherosclerosis, and Parkinson's disease. Various NLRP3 PTMs, including phosphorylation, ubiquitination, and SUMOylation, could direct inflammasome activation and control inflammation severity by affecting the protein stability, ATPase activity, subcellular localization, and oligomerization of NLRP3 as well as the association between NLRP3 and other inflammasome components. Here, we provide an overview of the PTMs of NLRP3 and their roles in controlling inflammation and summarize potential anti‐inflammatory drugs targeting NLRP3 PTMs.Keywords
Funding Information
- National Natural Science Foundation of China (82125020)
- China Postdoctoral Science Foundation (2022TQ0190, 2022M721930)
- Academy of Medical Sciences (NAF∖R1∖180232)
This publication has 78 references indexed in Scilit:
- Enteropathogenic Escherichia coli Uses NleA to Inhibit NLRP3 Inflammasome ActivationPLOS Pathogens, 2015
- Lipopolysaccharide Primes the NALP3 Inflammasome by Inhibiting Its Ubiquitination and Degradation Mediated by the SCFFBXL2 E3 LigaseJournal of Biological Chemistry, 2015
- NLRP3 at the interface of metabolism and inflammationImmunological Reviews, 2015
- Dopamine Controls Systemic Inflammation through Inhibition of NLRP3 InflammasomeCell, 2015
- ADP-Ribosylation of NLRP3 by Mycoplasma pneumoniae CARDS Toxin Regulates Inflammasome ActivitymBio, 2014
- Nitric oxide suppresses NLRP3 inflammasome activation and protects against LPS-induced septic shockCell Research, 2013
- Deubiquitination of NLRP3 by BRCC3 Critically Regulates Inflammasome ActivityMolecular Cell, 2013
- Cutting Edge: Nitric Oxide Inhibits the NLRP3 InflammasomeThe Journal of Immunology, 2012
- Nitric oxide controls the immunopathology of tuberculosis by inhibiting NLRP3 inflammasome–dependent processing of IL-1βNature Immunology, 2012
- The Src family kinase, Lyn, suppresses osteoclastogenesis in vitro and in vivoProceedings of the National Academy of Sciences, 2009